Related Experiment Video
Updated: Jun 9, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Clinical Characteristics and Current Treatment Modality of Preterm Infants with Ureaplasma spp. Infection
Zhenhai Zhang1, Jian Wang1, Wenwen Chen1
1Zhangzhou Affiliated Hospital, Fujian Medical University, Zhangzhou 363000, China.
Insights
Gestational age and maternal colonization predict Ureaplasma in neonates. Elevated white blood cell count with normal C-reactive protein indicates colonization/infection, guiding treatment decisions.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Respiratory Medicine
Background:
- Ureaplasma spp. colonization in neonates is controversial, with unclear impacts and management strategies.
- This study investigates perinatal predictors and clinical outcomes of Ureaplasma spp. respiratory colonization in preterm infants.
Purpose of the Study:
- To identify perinatal factors predicting Ureaplasma spp. colonization in neonatal respiratory tracts.
- To analyze the clinical course of Ureaplasma spp.-colonized infants.
- To provide evidence for diagnosis, treatment, and future research on Ureaplasma spp. in neonates.
Main Methods:
- Retrospective observational study.
- Inclusion criteria: infants born at gestational age (GA) < 32 weeks.
- Analysis of Ureaplasma spp. colonization, perinatal factors, and clinical outcomes.
Main Results:
- Ureaplasma spp. colonization prevalence was 25.8%, increasing with lower GA and birth weight (BW).
- Maternal vaginal colonization significantly increased neonatal risk (OR 7.8).
- Colonized infants showed higher WBC, normal CRP, and increased rates of mechanical ventilation weaning failure, interstitial pneumonia, and bronchopulmonary dysplasia.
Conclusions:
- GA and maternal vaginal colonization are key predictors of neonatal respiratory Ureaplasma spp. colonization.
- Elevated WBC with normal CRP serves as a marker for Ureaplasma spp. colonization/infection.
- Current treatment practices for deteriorating respiratory conditions warrant further investigation, considering GA's role.
Background:
The impact of and countermeasures for Ureaplasma spp. in neonates remain controversial. The aim of this study was to evaluate the associated perinatal factors that can predict the likelihood of respiratory tract Ureaplasma spp. colonization and analyze the subsequent clinical course of affected infants, thereby providing the rationale for their diagnosis, treatment, and future study.
Methods:
This was a retrospective observational study of infants born at a gestational age (GA) of less than 32 weeks.
Results:
The prevalence of respiratory tract Ureaplasma spp. colonization was 25.8% (75/291), and it increased with a decrease in GA and birth weight (BW). Maternal vaginal Ureaplasma spp. colonization increased the risk of neonatal Ureaplasma spp. colonization, with an OR of 7.8 (95% CI: 3.1, 20.0). Infants with Ureaplasma spp. colonization had a higher white blood cell (WBC) count, normal C-reactive protein (CRP) level, and higher failure rate of weaning from mechanical ventilation (30.7% vs. 17.1%, p = 0.014); they also suffered more from interstitial pneumonia (20.0% vs. 5.6%, p < 0.001) and bronchopulmonary dysplasia (36.0% vs. 13.4%, p < 0.001). Infants receiving anti-Ureaplasma spp. treatment had a lower GA, lower BW, and more severe respiratory syndromes. However, the difference in respiratory manifestation became insignificant after adjusting for GA.
Conclusions:
GA and maternal vaginal Ureaplasma spp. colonization could be used to predict neonatal respiratory tract Ureaplasma spp. colonization. An elevated WBC count combined with normal CRP is a good marker of Ureaplasma spp. colonization/infection. It is conventional practice to start anti-Ureaplasma spp. treatment when infants present with a deteriorated respiratory condition. This practice warrants further investigation considering GA as a predominant intermediate variable.
Related Concept Videos
Sexually Transmitted Infections
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Bacterial Phylum Chlamydiae
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

